Global Generic Drugs Market Size, Manufacturers, Opportunities and Forecast to 2030
Summary
A generic drug is a pharmaceutical drug that is equivalent to a brand-name product in dosage, strength, route of administration, quality, performance, and intended use. The term may also refer to any drug marketed under its chemical name without advertising, or to the chemical makeup of a drug rather than the brand name under which the drug is sold.
According to APO Research, The global Generic Drugs market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Generic Drugs is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Generic Drugs is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Generic Drugs is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Generic Drugs include Teva, Novartis - Sandoz, Mylan, Sun Pharmaceutical, Aspen, Fresenius Kabi, Pfizer (Hospira), Sanofi and Aurobindo, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Generic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Generic Drugs.
The Generic Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Generic Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, gross margin by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Generic Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Generic Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Generic Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2019-2024, 2025-2030). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Generic Drugs companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
A generic drug is a pharmaceutical drug that is equivalent to a brand-name product in dosage, strength, route of administration, quality, performance, and intended use. The term may also refer to any drug marketed under its chemical name without advertising, or to the chemical makeup of a drug rather than the brand name under which the drug is sold.
According to APO Research, The global Generic Drugs market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Generic Drugs is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Generic Drugs is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Generic Drugs is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Generic Drugs include Teva, Novartis - Sandoz, Mylan, Sun Pharmaceutical, Aspen, Fresenius Kabi, Pfizer (Hospira), Sanofi and Aurobindo, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Generic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Generic Drugs.
The Generic Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Generic Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, gross margin by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Teva
- Novartis - Sandoz
- Mylan
- Sun Pharmaceutical
- Aspen
- Fresenius Kabi
- Pfizer (Hospira)
- Sanofi
- Aurobindo
- Lupin
- Dr. Reddy's
- Apotex
- Cipla
- ENDO (Par Pharmaceutical)
- Stada Arzneimittel
- Krka Group
- Nichi-Iko Pharmaceutical
- Valeant
- Zydus Cadila
- Hikma
- Pharmaniaga Berhad
- Hovid Berhad
- Duopharma Biotech
- Kotra Pharma
- HOE Pharmaceutical
- Y.S.P. Industries
- Prescription
- Non-Prescription Drugs
- Hospital
- Clinic
- Others
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Generic Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Generic Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Generic Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2019-2024, 2025-2030). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Generic Drugs companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Market Growth Prospects
1.3 Global Generic Drugs Market Size Overview by Region 2019 VS 2023 VS 2030
1.4 Global Generic Drugs Market Size by Region (2019-2030)
1.4.1 Global Generic Drugs Market Size by Region (2019-2024)
1.4.2 Global Generic Drugs Market Size by Region (2025-2030)
1.5 Key Regions Generic Drugs Market Size (2019-2030)
1.5.1 North America Generic Drugs Market Size Growth Rate (2019-2030)
1.5.2 Europe Generic Drugs Market Size Growth Rate (2019-2030)
1.5.3 Asia-Pacific Generic Drugs Market Size Growth Rate (2019-2030)
1.5.4 Latin America Generic Drugs Market Size Growth Rate (2019-2030)
1.5.5 Middle East & Africa Generic Drugs Market Size Growth Rate (2019-2030)
2 GENERIC DRUGS MARKET BY TYPE
2.1 Type Introduction
2.1.1 Prescription
2.1.2 Non-Prescription Drugs
2.2 Global Generic Drugs Market Size by Type
2.2.1 Global Generic Drugs Market Size Overview by Type (2019-2030)
2.2.2 Global Generic Drugs Historic Market Size Review by Type (2019-2024)
2.2.3 Global Generic Drugs Market Size Forecasted by Type (2025-2030)
2.3 Global Generic Drugs Market Size by Regions
2.3.1 North America Generic Drugs Market Size Breakdown by Type (2019-2024)
2.3.2 Europe Generic Drugs Market Size Breakdown by Type (2019-2024)
2.3.3 Asia-Pacific Generic Drugs Market Size Breakdown by Type (2019-2024)
2.3.4 Latin America Generic Drugs Market Size Breakdown by Type (2019-2024)
2.3.5 Middle East and Africa Generic Drugs Market Size Breakdown by Type (2019-2024)
3 GENERIC DRUGS MARKET BY APPLICATION
3.1 Type Introduction
3.1.1 Hospital
3.1.2 Clinic
3.1.3 Others
3.2 Global Generic Drugs Market Size by Application
3.2.1 Global Generic Drugs Market Size Overview by Application (2019-2030)
3.2.2 Global Generic Drugs Historic Market Size Review by Application (2019-2024)
3.2.3 Global Generic Drugs Market Size Forecasted by Application (2025-2030)
3.3 Global Generic Drugs Market Size by Regions
3.3.1 North America Generic Drugs Market Size Breakdown by Application (2019-2024)
3.3.2 Europe Generic Drugs Market Size Breakdown by Application (2019-2024)
3.3.3 Asia-Pacific Generic Drugs Market Size Breakdown by Application (2019-2024)
3.3.4 Latin America Generic Drugs Market Size Breakdown by Application (2019-2024)
3.3.5 Middle East and Africa Generic Drugs Market Size Breakdown by Application (2019-2024)
4 GLOBAL MARKET DYNAMICS
4.1 Generic Drugs Industry Trends
4.2 Generic Drugs Industry Drivers
4.3 Generic Drugs Industry Opportunities and Challenges
4.4 Generic Drugs Industry Restraints
5 COMPETITIVE INSIGHTS BY COMPANY
5.1 Global Top Players by Generic Drugs Revenue (2019-2024)
5.2 Global Generic Drugs Industry Company Ranking, 2022 VS 2023 VS 2024
5.3 Global Generic Drugs Key Company Headquarters & Area Served
5.4 Global Generic Drugs Company, Product Type & Application
5.5 Global Generic Drugs Company Commercialization Time
5.6 Market Competitive Analysis
5.6.1 Global Generic Drugs Market CR5 and HHI
5.6.2 Global Top 5 and 10 Generic Drugs Players Market Share by Revenue in 2023
5.6.3 2023 Generic Drugs Tier 1, Tier 2, and Tier
6 COMPANY PROFILES
6.1 Teva
6.1.1 Teva Comapny Information
6.1.2 Teva Business Overview
6.1.3 Teva Generic Drugs Revenue, Global Share and Gross Margin (2019-2024)
6.1.4 Teva Generic Drugs Product Portfolio
6.1.5 Teva Recent Developments
6.2 Novartis - Sandoz
6.2.1 Novartis - Sandoz Comapny Information
6.2.2 Novartis - Sandoz Business Overview
6.2.3 Novartis - Sandoz Generic Drugs Revenue, Global Share and Gross Margin (2019-2024)
6.2.4 Novartis - Sandoz Generic Drugs Product Portfolio
6.2.5 Novartis - Sandoz Recent Developments
6.3 Mylan
6.3.1 Mylan Comapny Information
6.3.2 Mylan Business Overview
6.3.3 Mylan Generic Drugs Revenue, Global Share and Gross Margin (2019-2024)
6.3.4 Mylan Generic Drugs Product Portfolio
6.3.5 Mylan Recent Developments
6.4 Sun Pharmaceutical
6.4.1 Sun Pharmaceutical Comapny Information
6.4.2 Sun Pharmaceutical Business Overview
6.4.3 Sun Pharmaceutical Generic Drugs Revenue, Global Share and Gross Margin (2019-2024)
6.4.4 Sun Pharmaceutical Generic Drugs Product Portfolio
6.4.5 Sun Pharmaceutical Recent Developments
6.5 Aspen
6.5.1 Aspen Comapny Information
6.5.2 Aspen Business Overview
6.5.3 Aspen Generic Drugs Revenue, Global Share and Gross Margin (2019-2024)
6.5.4 Aspen Generic Drugs Product Portfolio
6.5.5 Aspen Recent Developments
6.6 Fresenius Kabi
6.6.1 Fresenius Kabi Comapny Information
6.6.2 Fresenius Kabi Business Overview
6.6.3 Fresenius Kabi Generic Drugs Revenue, Global Share and Gross Margin (2019-2024)
6.6.4 Fresenius Kabi Generic Drugs Product Portfolio
6.6.5 Fresenius Kabi Recent Developments
6.7 Pfizer (Hospira)
6.7.1 Pfizer (Hospira) Comapny Information
6.7.2 Pfizer (Hospira) Business Overview
6.7.3 Pfizer (Hospira) Generic Drugs Revenue, Global Share and Gross Margin (2019-2024)
6.7.4 Pfizer (Hospira) Generic Drugs Product Portfolio
6.7.5 Pfizer (Hospira) Recent Developments
6.8 Sanofi
6.8.1 Sanofi Comapny Information
6.8.2 Sanofi Business Overview
6.8.3 Sanofi Generic Drugs Revenue, Global Share and Gross Margin (2019-2024)
6.8.4 Sanofi Generic Drugs Product Portfolio
6.8.5 Sanofi Recent Developments
6.9 Aurobindo
6.9.1 Aurobindo Comapny Information
6.9.2 Aurobindo Business Overview
6.9.3 Aurobindo Generic Drugs Revenue, Global Share and Gross Margin (2019-2024)
6.9.4 Aurobindo Generic Drugs Product Portfolio
6.9.5 Aurobindo Recent Developments
6.10 Lupin
6.10.1 Lupin Comapny Information
6.10.2 Lupin Business Overview
6.10.3 Lupin Generic Drugs Revenue, Global Share and Gross Margin (2019-2024)
6.10.4 Lupin Generic Drugs Product Portfolio
6.10.5 Lupin Recent Developments
6.11 Dr. Reddy's
6.11.1 Dr. Reddy's Comapny Information
6.11.2 Dr. Reddy's Business Overview
6.11.3 Dr. Reddy's Generic Drugs Revenue, Global Share and Gross Margin (2019-2024)
6.11.4 Dr. Reddy's Generic Drugs Product Portfolio
6.11.5 Dr. Reddy's Recent Developments
6.12 Apotex
6.12.1 Apotex Comapny Information
6.12.2 Apotex Business Overview
6.12.3 Apotex Generic Drugs Revenue, Global Share and Gross Margin (2019-2024)
6.12.4 Apotex Generic Drugs Product Portfolio
6.12.5 Apotex Recent Developments
6.13 Cipla
6.13.1 Cipla Comapny Information
6.13.2 Cipla Business Overview
6.13.3 Cipla Generic Drugs Revenue, Global Share and Gross Margin (2019-2024)
6.13.4 Cipla Generic Drugs Product Portfolio
6.13.5 Cipla Recent Developments
6.14 ENDO (Par Pharmaceutical)
6.14.1 ENDO (Par Pharmaceutical) Comapny Information
6.14.2 ENDO (Par Pharmaceutical) Business Overview
6.14.3 ENDO (Par Pharmaceutical) Generic Drugs Revenue, Global Share and Gross Margin (2019-2024)
6.14.4 ENDO (Par Pharmaceutical) Generic Drugs Product Portfolio
6.14.5 ENDO (Par Pharmaceutical) Recent Developments
6.15 Stada Arzneimittel
6.15.1 Stada Arzneimittel Comapny Information
6.15.2 Stada Arzneimittel Business Overview
6.15.3 Stada Arzneimittel Generic Drugs Revenue, Global Share and Gross Margin (2019-2024)
6.15.4 Stada Arzneimittel Generic Drugs Product Portfolio
6.15.5 Stada Arzneimittel Recent Developments
6.16 Krka Group
6.16.1 Krka Group Comapny Information
6.16.2 Krka Group Business Overview
6.16.3 Krka Group Generic Drugs Revenue, Global Share and Gross Margin (2019-2024)
6.16.4 Krka Group Generic Drugs Product Portfolio
6.16.5 Krka Group Recent Developments
6.17 Nichi-Iko Pharmaceutical
6.17.1 Nichi-Iko Pharmaceutical Comapny Information
6.17.2 Nichi-Iko Pharmaceutical Business Overview
6.17.3 Nichi-Iko Pharmaceutical Generic Drugs Revenue, Global Share and Gross Margin (2019-2024)
6.17.4 Nichi-Iko Pharmaceutical Generic Drugs Product Portfolio
6.17.5 Nichi-Iko Pharmaceutical Recent Developments
6.18 Valeant
6.18.1 Valeant Comapny Information
6.18.2 Valeant Business Overview
6.18.3 Valeant Generic Drugs Revenue, Global Share and Gross Margin (2019-2024)
6.18.4 Valeant Generic Drugs Product Portfolio
6.18.5 Valeant Recent Developments
6.19 Zydus Cadila
6.19.1 Zydus Cadila Comapny Information
6.19.2 Zydus Cadila Business Overview
6.19.3 Zydus Cadila Generic Drugs Revenue, Global Share and Gross Margin (2019-2024)
6.19.4 Zydus Cadila Generic Drugs Product Portfolio
6.19.5 Zydus Cadila Recent Developments
6.20 Hikma
6.20.1 Hikma Comapny Information
6.20.2 Hikma Business Overview
6.20.3 Hikma Generic Drugs Revenue, Global Share and Gross Margin (2019-2024)
6.20.4 Hikma Generic Drugs Product Portfolio
6.20.5 Hikma Recent Developments
6.21 Pharmaniaga Berhad
6.21.1 Pharmaniaga Berhad Comapny Information
6.21.2 Pharmaniaga Berhad Business Overview
6.21.3 Pharmaniaga Berhad Generic Drugs Revenue, Global Share and Gross Margin (2019-2024)
6.21.4 Pharmaniaga Berhad Generic Drugs Product Portfolio
6.21.5 Pharmaniaga Berhad Recent Developments
6.22 Hovid Berhad
6.22.1 Hovid Berhad Comapny Information
6.22.2 Hovid Berhad Business Overview
6.22.3 Hovid Berhad Generic Drugs Revenue, Global Share and Gross Margin (2019-2024)
6.22.4 Hovid Berhad Generic Drugs Product Portfolio
6.22.5 Hovid Berhad Recent Developments
6.23 Duopharma Biotech
6.23.1 Duopharma Biotech Comapny Information
6.23.2 Duopharma Biotech Business Overview
6.23.3 Duopharma Biotech Generic Drugs Revenue, Global Share and Gross Margin (2019-2024)
6.23.4 Duopharma Biotech Generic Drugs Product Portfolio
6.23.5 Duopharma Biotech Recent Developments
6.24 Kotra Pharma
6.24.1 Kotra Pharma Comapny Information
6.24.2 Kotra Pharma Business Overview
6.24.3 Kotra Pharma Generic Drugs Revenue, Global Share and Gross Margin (2019-2024)
6.24.4 Kotra Pharma Generic Drugs Product Portfolio
6.24.5 Kotra Pharma Recent Developments
6.25 HOE Pharmaceutical
6.25.1 HOE Pharmaceutical Comapny Information
6.25.2 HOE Pharmaceutical Business Overview
6.25.3 HOE Pharmaceutical Generic Drugs Revenue, Global Share and Gross Margin (2019-2024)
6.25.4 HOE Pharmaceutical Generic Drugs Product Portfolio
6.25.5 HOE Pharmaceutical Recent Developments
6.26 Y.S.P. Industries
6.26.1 Y.S.P. Industries Comapny Information
6.26.2 Y.S.P. Industries Business Overview
6.26.3 Y.S.P. Industries Generic Drugs Revenue, Global Share and Gross Margin (2019-2024)
6.26.4 Y.S.P. Industries Generic Drugs Product Portfolio
6.26.5 Y.S.P. Industries Recent Developments
7 NORTH AMERICA
7.1 North America Generic Drugs Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2 North America Generic Drugs Market Size by Country (2019-2024)
7.3 North America Generic Drugs Market Size Forecast by Country (2025-2030)
8 EUROPE
8.1 Europe Generic Drugs Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2 Europe Generic Drugs Market Size by Country (2019-2024)
8.3 Europe Generic Drugs Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Generic Drugs Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2 Asia-Pacific Generic Drugs Market Size by Country (2019-2024)
9.3 Asia-Pacific Generic Drugs Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA
10.1 Latin America Generic Drugs Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2 Latin America Generic Drugs Market Size by Country (2019-2024)
10.3 Latin America Generic Drugs Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Generic Drugs Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2 Middle East & Africa Generic Drugs Market Size by Country (2019-2024)
11.3 Middle East & Africa Generic Drugs Market Size Forecast by Country (2025-2030)
12 CONCLUDING INSIGHTS
13 APPENDIX
13.1 Reasons for Doing This Study
13.2 Research Methodology
13.3 Research Process
13.4 Authors List of This Report
13.5 Data Source
13.5.1 Secondary Sources
13.5.2 Primary Sources
1.1 Product Definition
1.2 Global Market Growth Prospects
1.3 Global Generic Drugs Market Size Overview by Region 2019 VS 2023 VS 2030
1.4 Global Generic Drugs Market Size by Region (2019-2030)
1.4.1 Global Generic Drugs Market Size by Region (2019-2024)
1.4.2 Global Generic Drugs Market Size by Region (2025-2030)
1.5 Key Regions Generic Drugs Market Size (2019-2030)
1.5.1 North America Generic Drugs Market Size Growth Rate (2019-2030)
1.5.2 Europe Generic Drugs Market Size Growth Rate (2019-2030)
1.5.3 Asia-Pacific Generic Drugs Market Size Growth Rate (2019-2030)
1.5.4 Latin America Generic Drugs Market Size Growth Rate (2019-2030)
1.5.5 Middle East & Africa Generic Drugs Market Size Growth Rate (2019-2030)
2 GENERIC DRUGS MARKET BY TYPE
2.1 Type Introduction
2.1.1 Prescription
2.1.2 Non-Prescription Drugs
2.2 Global Generic Drugs Market Size by Type
2.2.1 Global Generic Drugs Market Size Overview by Type (2019-2030)
2.2.2 Global Generic Drugs Historic Market Size Review by Type (2019-2024)
2.2.3 Global Generic Drugs Market Size Forecasted by Type (2025-2030)
2.3 Global Generic Drugs Market Size by Regions
2.3.1 North America Generic Drugs Market Size Breakdown by Type (2019-2024)
2.3.2 Europe Generic Drugs Market Size Breakdown by Type (2019-2024)
2.3.3 Asia-Pacific Generic Drugs Market Size Breakdown by Type (2019-2024)
2.3.4 Latin America Generic Drugs Market Size Breakdown by Type (2019-2024)
2.3.5 Middle East and Africa Generic Drugs Market Size Breakdown by Type (2019-2024)
3 GENERIC DRUGS MARKET BY APPLICATION
3.1 Type Introduction
3.1.1 Hospital
3.1.2 Clinic
3.1.3 Others
3.2 Global Generic Drugs Market Size by Application
3.2.1 Global Generic Drugs Market Size Overview by Application (2019-2030)
3.2.2 Global Generic Drugs Historic Market Size Review by Application (2019-2024)
3.2.3 Global Generic Drugs Market Size Forecasted by Application (2025-2030)
3.3 Global Generic Drugs Market Size by Regions
3.3.1 North America Generic Drugs Market Size Breakdown by Application (2019-2024)
3.3.2 Europe Generic Drugs Market Size Breakdown by Application (2019-2024)
3.3.3 Asia-Pacific Generic Drugs Market Size Breakdown by Application (2019-2024)
3.3.4 Latin America Generic Drugs Market Size Breakdown by Application (2019-2024)
3.3.5 Middle East and Africa Generic Drugs Market Size Breakdown by Application (2019-2024)
4 GLOBAL MARKET DYNAMICS
4.1 Generic Drugs Industry Trends
4.2 Generic Drugs Industry Drivers
4.3 Generic Drugs Industry Opportunities and Challenges
4.4 Generic Drugs Industry Restraints
5 COMPETITIVE INSIGHTS BY COMPANY
5.1 Global Top Players by Generic Drugs Revenue (2019-2024)
5.2 Global Generic Drugs Industry Company Ranking, 2022 VS 2023 VS 2024
5.3 Global Generic Drugs Key Company Headquarters & Area Served
5.4 Global Generic Drugs Company, Product Type & Application
5.5 Global Generic Drugs Company Commercialization Time
5.6 Market Competitive Analysis
5.6.1 Global Generic Drugs Market CR5 and HHI
5.6.2 Global Top 5 and 10 Generic Drugs Players Market Share by Revenue in 2023
5.6.3 2023 Generic Drugs Tier 1, Tier 2, and Tier
6 COMPANY PROFILES
6.1 Teva
6.1.1 Teva Comapny Information
6.1.2 Teva Business Overview
6.1.3 Teva Generic Drugs Revenue, Global Share and Gross Margin (2019-2024)
6.1.4 Teva Generic Drugs Product Portfolio
6.1.5 Teva Recent Developments
6.2 Novartis - Sandoz
6.2.1 Novartis - Sandoz Comapny Information
6.2.2 Novartis - Sandoz Business Overview
6.2.3 Novartis - Sandoz Generic Drugs Revenue, Global Share and Gross Margin (2019-2024)
6.2.4 Novartis - Sandoz Generic Drugs Product Portfolio
6.2.5 Novartis - Sandoz Recent Developments
6.3 Mylan
6.3.1 Mylan Comapny Information
6.3.2 Mylan Business Overview
6.3.3 Mylan Generic Drugs Revenue, Global Share and Gross Margin (2019-2024)
6.3.4 Mylan Generic Drugs Product Portfolio
6.3.5 Mylan Recent Developments
6.4 Sun Pharmaceutical
6.4.1 Sun Pharmaceutical Comapny Information
6.4.2 Sun Pharmaceutical Business Overview
6.4.3 Sun Pharmaceutical Generic Drugs Revenue, Global Share and Gross Margin (2019-2024)
6.4.4 Sun Pharmaceutical Generic Drugs Product Portfolio
6.4.5 Sun Pharmaceutical Recent Developments
6.5 Aspen
6.5.1 Aspen Comapny Information
6.5.2 Aspen Business Overview
6.5.3 Aspen Generic Drugs Revenue, Global Share and Gross Margin (2019-2024)
6.5.4 Aspen Generic Drugs Product Portfolio
6.5.5 Aspen Recent Developments
6.6 Fresenius Kabi
6.6.1 Fresenius Kabi Comapny Information
6.6.2 Fresenius Kabi Business Overview
6.6.3 Fresenius Kabi Generic Drugs Revenue, Global Share and Gross Margin (2019-2024)
6.6.4 Fresenius Kabi Generic Drugs Product Portfolio
6.6.5 Fresenius Kabi Recent Developments
6.7 Pfizer (Hospira)
6.7.1 Pfizer (Hospira) Comapny Information
6.7.2 Pfizer (Hospira) Business Overview
6.7.3 Pfizer (Hospira) Generic Drugs Revenue, Global Share and Gross Margin (2019-2024)
6.7.4 Pfizer (Hospira) Generic Drugs Product Portfolio
6.7.5 Pfizer (Hospira) Recent Developments
6.8 Sanofi
6.8.1 Sanofi Comapny Information
6.8.2 Sanofi Business Overview
6.8.3 Sanofi Generic Drugs Revenue, Global Share and Gross Margin (2019-2024)
6.8.4 Sanofi Generic Drugs Product Portfolio
6.8.5 Sanofi Recent Developments
6.9 Aurobindo
6.9.1 Aurobindo Comapny Information
6.9.2 Aurobindo Business Overview
6.9.3 Aurobindo Generic Drugs Revenue, Global Share and Gross Margin (2019-2024)
6.9.4 Aurobindo Generic Drugs Product Portfolio
6.9.5 Aurobindo Recent Developments
6.10 Lupin
6.10.1 Lupin Comapny Information
6.10.2 Lupin Business Overview
6.10.3 Lupin Generic Drugs Revenue, Global Share and Gross Margin (2019-2024)
6.10.4 Lupin Generic Drugs Product Portfolio
6.10.5 Lupin Recent Developments
6.11 Dr. Reddy's
6.11.1 Dr. Reddy's Comapny Information
6.11.2 Dr. Reddy's Business Overview
6.11.3 Dr. Reddy's Generic Drugs Revenue, Global Share and Gross Margin (2019-2024)
6.11.4 Dr. Reddy's Generic Drugs Product Portfolio
6.11.5 Dr. Reddy's Recent Developments
6.12 Apotex
6.12.1 Apotex Comapny Information
6.12.2 Apotex Business Overview
6.12.3 Apotex Generic Drugs Revenue, Global Share and Gross Margin (2019-2024)
6.12.4 Apotex Generic Drugs Product Portfolio
6.12.5 Apotex Recent Developments
6.13 Cipla
6.13.1 Cipla Comapny Information
6.13.2 Cipla Business Overview
6.13.3 Cipla Generic Drugs Revenue, Global Share and Gross Margin (2019-2024)
6.13.4 Cipla Generic Drugs Product Portfolio
6.13.5 Cipla Recent Developments
6.14 ENDO (Par Pharmaceutical)
6.14.1 ENDO (Par Pharmaceutical) Comapny Information
6.14.2 ENDO (Par Pharmaceutical) Business Overview
6.14.3 ENDO (Par Pharmaceutical) Generic Drugs Revenue, Global Share and Gross Margin (2019-2024)
6.14.4 ENDO (Par Pharmaceutical) Generic Drugs Product Portfolio
6.14.5 ENDO (Par Pharmaceutical) Recent Developments
6.15 Stada Arzneimittel
6.15.1 Stada Arzneimittel Comapny Information
6.15.2 Stada Arzneimittel Business Overview
6.15.3 Stada Arzneimittel Generic Drugs Revenue, Global Share and Gross Margin (2019-2024)
6.15.4 Stada Arzneimittel Generic Drugs Product Portfolio
6.15.5 Stada Arzneimittel Recent Developments
6.16 Krka Group
6.16.1 Krka Group Comapny Information
6.16.2 Krka Group Business Overview
6.16.3 Krka Group Generic Drugs Revenue, Global Share and Gross Margin (2019-2024)
6.16.4 Krka Group Generic Drugs Product Portfolio
6.16.5 Krka Group Recent Developments
6.17 Nichi-Iko Pharmaceutical
6.17.1 Nichi-Iko Pharmaceutical Comapny Information
6.17.2 Nichi-Iko Pharmaceutical Business Overview
6.17.3 Nichi-Iko Pharmaceutical Generic Drugs Revenue, Global Share and Gross Margin (2019-2024)
6.17.4 Nichi-Iko Pharmaceutical Generic Drugs Product Portfolio
6.17.5 Nichi-Iko Pharmaceutical Recent Developments
6.18 Valeant
6.18.1 Valeant Comapny Information
6.18.2 Valeant Business Overview
6.18.3 Valeant Generic Drugs Revenue, Global Share and Gross Margin (2019-2024)
6.18.4 Valeant Generic Drugs Product Portfolio
6.18.5 Valeant Recent Developments
6.19 Zydus Cadila
6.19.1 Zydus Cadila Comapny Information
6.19.2 Zydus Cadila Business Overview
6.19.3 Zydus Cadila Generic Drugs Revenue, Global Share and Gross Margin (2019-2024)
6.19.4 Zydus Cadila Generic Drugs Product Portfolio
6.19.5 Zydus Cadila Recent Developments
6.20 Hikma
6.20.1 Hikma Comapny Information
6.20.2 Hikma Business Overview
6.20.3 Hikma Generic Drugs Revenue, Global Share and Gross Margin (2019-2024)
6.20.4 Hikma Generic Drugs Product Portfolio
6.20.5 Hikma Recent Developments
6.21 Pharmaniaga Berhad
6.21.1 Pharmaniaga Berhad Comapny Information
6.21.2 Pharmaniaga Berhad Business Overview
6.21.3 Pharmaniaga Berhad Generic Drugs Revenue, Global Share and Gross Margin (2019-2024)
6.21.4 Pharmaniaga Berhad Generic Drugs Product Portfolio
6.21.5 Pharmaniaga Berhad Recent Developments
6.22 Hovid Berhad
6.22.1 Hovid Berhad Comapny Information
6.22.2 Hovid Berhad Business Overview
6.22.3 Hovid Berhad Generic Drugs Revenue, Global Share and Gross Margin (2019-2024)
6.22.4 Hovid Berhad Generic Drugs Product Portfolio
6.22.5 Hovid Berhad Recent Developments
6.23 Duopharma Biotech
6.23.1 Duopharma Biotech Comapny Information
6.23.2 Duopharma Biotech Business Overview
6.23.3 Duopharma Biotech Generic Drugs Revenue, Global Share and Gross Margin (2019-2024)
6.23.4 Duopharma Biotech Generic Drugs Product Portfolio
6.23.5 Duopharma Biotech Recent Developments
6.24 Kotra Pharma
6.24.1 Kotra Pharma Comapny Information
6.24.2 Kotra Pharma Business Overview
6.24.3 Kotra Pharma Generic Drugs Revenue, Global Share and Gross Margin (2019-2024)
6.24.4 Kotra Pharma Generic Drugs Product Portfolio
6.24.5 Kotra Pharma Recent Developments
6.25 HOE Pharmaceutical
6.25.1 HOE Pharmaceutical Comapny Information
6.25.2 HOE Pharmaceutical Business Overview
6.25.3 HOE Pharmaceutical Generic Drugs Revenue, Global Share and Gross Margin (2019-2024)
6.25.4 HOE Pharmaceutical Generic Drugs Product Portfolio
6.25.5 HOE Pharmaceutical Recent Developments
6.26 Y.S.P. Industries
6.26.1 Y.S.P. Industries Comapny Information
6.26.2 Y.S.P. Industries Business Overview
6.26.3 Y.S.P. Industries Generic Drugs Revenue, Global Share and Gross Margin (2019-2024)
6.26.4 Y.S.P. Industries Generic Drugs Product Portfolio
6.26.5 Y.S.P. Industries Recent Developments
7 NORTH AMERICA
7.1 North America Generic Drugs Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2 North America Generic Drugs Market Size by Country (2019-2024)
7.3 North America Generic Drugs Market Size Forecast by Country (2025-2030)
8 EUROPE
8.1 Europe Generic Drugs Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2 Europe Generic Drugs Market Size by Country (2019-2024)
8.3 Europe Generic Drugs Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Generic Drugs Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2 Asia-Pacific Generic Drugs Market Size by Country (2019-2024)
9.3 Asia-Pacific Generic Drugs Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA
10.1 Latin America Generic Drugs Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2 Latin America Generic Drugs Market Size by Country (2019-2024)
10.3 Latin America Generic Drugs Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Generic Drugs Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2 Middle East & Africa Generic Drugs Market Size by Country (2019-2024)
11.3 Middle East & Africa Generic Drugs Market Size Forecast by Country (2025-2030)
12 CONCLUDING INSIGHTS
13 APPENDIX
13.1 Reasons for Doing This Study
13.2 Research Methodology
13.3 Research Process
13.4 Authors List of This Report
13.5 Data Source
13.5.1 Secondary Sources
13.5.2 Primary Sources
LIST OF TABLES
Table 1. Global Generic Drugs Market Size (US$ Million) Comparison by Region: 2019 VS 2023 VS 2030
Table 2. Global Generic Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 3. Global Generic Drugs Market Share by Region (2019-2024)
Table 4. Global Generic Drugs Market Size by Region (2025-2030) & (US$ Million)
Table 5. Global Generic Drugs Market Share by Region (2025-2030)
Table 6. Global Generic Drugs Market Size by Type (2019 VS 2023 VS 2030) & (US$ Million)
Table 7. Global Generic Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 8. Global Generic Drugs Market Size Share by Type (2019-2024)
Table 9. Global Generic Drugs Market Size Forecasted by Type (2025-2030) & (US$ Million)
Table 10. Global Generic Drugs Market Size Share Forecasted by Type (2025-2030)
Table 11. North America Generic Drugs Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 12. North America Generic Drugs Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 13. Europe Generic Drugs Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 14. Europe Generic Drugs Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 15. Asia-Pacific Generic Drugs Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 16. Asia-Pacific Generic Drugs Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 17. Latin America Generic Drugs Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 18. Latin America Generic Drugs Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 19. Middle East and Africa Generic Drugs Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 20. Middle East and Africa Generic Drugs Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 21. Global Generic Drugs Market Size by Application (2019 VS 2023 VS 2030) & (US$ Million)
Table 22. Global Generic Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 23. Global Generic Drugs Market Size Share by Application (2019-2024)
Table 24. Global Generic Drugs Market Size Forecasted by Application (2025-2030) & (US$ Million)
Table 25. Global Generic Drugs Market Size Share Forecasted by Application (2025-2030)
Table 26. North America Generic Drugs Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 27. North America Generic Drugs Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 28. Europe Generic Drugs Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 29. Europe Generic Drugs Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 30. Asia-Pacific Generic Drugs Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 31. Asia-Pacific Generic Drugs Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 32. Latin America Generic Drugs Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 33. Latin America Generic Drugs Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 34. Middle East and Africa Generic Drugs Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 35. Middle East and Africa Generic Drugs Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 36. Generic Drugs Industry Trends
Table 37. Generic Drugs Industry Drivers
Table 38. Generic Drugs Industry Opportunities and Challenges
Table 39. Generic Drugs Industry Restraints
Table 40. Global Generic Drugs Revenue by Company (US$ Million) & (2019-2024)
Table 41. Global Generic Drugs Revenue Market Share by Company (2019-2024)
Table 42. Global Generic Drugs Industry Company Ranking, 2022 VS 2023 VS 2024
Table 43. Global Generic Drugs Key Company Headquarters & Area Served
Table 44. Global Generic Drugs Company, Product Type & Application
Table 45. Global Generic Drugs Company Commercialization Time
Table 46. Global Company Market Concentration Ratio (CR5 and HHI)
Table 47. Global Generic Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 48. Teva Business Overview
Table 49. Teva Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 50. Teva Generic Drugs Product Portfolio
Table 51. Teva Recent Development
Table 52. Novartis - Sandoz Company Information
Table 53. Novartis - Sandoz Business Overview
Table 54. Novartis - Sandoz Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 55. Novartis - Sandoz Generic Drugs Product Portfolio
Table 56. Novartis - Sandoz Recent Development
Table 57. Mylan Company Information
Table 58. Mylan Business Overview
Table 59. Mylan Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 60. Mylan Generic Drugs Product Portfolio
Table 61. Mylan Recent Development
Table 62. Sun Pharmaceutical Company Information
Table 63. Sun Pharmaceutical Business Overview
Table 64. Sun Pharmaceutical Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 65. Sun Pharmaceutical Generic Drugs Product Portfolio
Table 66. Sun Pharmaceutical Recent Development
Table 67. Aspen Company Information
Table 68. Aspen Business Overview
Table 69. Aspen Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 70. Aspen Generic Drugs Product Portfolio
Table 71. Aspen Recent Development
Table 72. Fresenius Kabi Company Information
Table 73. Fresenius Kabi Business Overview
Table 74. Fresenius Kabi Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 75. Fresenius Kabi Generic Drugs Product Portfolio
Table 76. Fresenius Kabi Recent Development
Table 77. Pfizer (Hospira) Company Information
Table 78. Pfizer (Hospira) Business Overview
Table 79. Pfizer (Hospira) Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 80. Pfizer (Hospira) Generic Drugs Product Portfolio
Table 81. Pfizer (Hospira) Recent Development
Table 82. Sanofi Company Information
Table 83. Sanofi Business Overview
Table 84. Sanofi Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 85. Sanofi Generic Drugs Product Portfolio
Table 86. Sanofi Recent Development
Table 87. Aurobindo Company Information
Table 88. Aurobindo Business Overview
Table 89. Aurobindo Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 90. Aurobindo Generic Drugs Product Portfolio
Table 91. Aurobindo Recent Development
Table 92. Lupin Company Information
Table 93. Lupin Business Overview
Table 94. Lupin Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 95. Lupin Generic Drugs Product Portfolio
Table 96. Lupin Recent Development
Table 97. Dr. Reddy's Company Information
Table 98. Dr. Reddy's Business Overview
Table 99. Dr. Reddy's Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 100. Dr. Reddy's Generic Drugs Product Portfolio
Table 101. Dr. Reddy's Recent Development
Table 102. Apotex Company Information
Table 103. Apotex Business Overview
Table 104. Apotex Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 105. Apotex Generic Drugs Product Portfolio
Table 106. Apotex Recent Development
Table 107. Cipla Company Information
Table 108. Cipla Business Overview
Table 109. Cipla Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 110. Cipla Generic Drugs Product Portfolio
Table 111. Cipla Recent Development
Table 112. ENDO (Par Pharmaceutical) Company Information
Table 113. ENDO (Par Pharmaceutical) Business Overview
Table 114. ENDO (Par Pharmaceutical) Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 115. ENDO (Par Pharmaceutical) Generic Drugs Product Portfolio
Table 116. ENDO (Par Pharmaceutical) Recent Development
Table 117. Stada Arzneimittel Company Information
Table 118. Stada Arzneimittel Business Overview
Table 119. Stada Arzneimittel Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 120. Stada Arzneimittel Generic Drugs Product Portfolio
Table 121. Stada Arzneimittel Recent Development
Table 122. Krka Group Company Information
Table 123. Krka Group Business Overview
Table 124. Krka Group Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 125. Krka Group Generic Drugs Product Portfolio
Table 126. Krka Group Recent Development
Table 127. Nichi-Iko Pharmaceutical Company Information
Table 128. Nichi-Iko Pharmaceutical Business Overview
Table 129. Nichi-Iko Pharmaceutical Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 130. Nichi-Iko Pharmaceutical Generic Drugs Product Portfolio
Table 131. Nichi-Iko Pharmaceutical Recent Development
Table 132. Valeant Company Information
Table 133. Valeant Business Overview
Table 134. Valeant Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 135. Valeant Generic Drugs Product Portfolio
Table 136. Valeant Recent Development
Table 137. Zydus Cadila Company Information
Table 138. Zydus Cadila Business Overview
Table 139. Zydus Cadila Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 140. Zydus Cadila Generic Drugs Product Portfolio
Table 141. Zydus Cadila Recent Development
Table 142. Hikma Company Information
Table 143. Hikma Business Overview
Table 144. Hikma Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 145. Hikma Generic Drugs Product Portfolio
Table 146. Hikma Recent Development
Table 147. Pharmaniaga Berhad Company Information
Table 148. Pharmaniaga Berhad Business Overview
Table 149. Pharmaniaga Berhad Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 150. Pharmaniaga Berhad Generic Drugs Product Portfolio
Table 151. Pharmaniaga Berhad Recent Development
Table 152. Hovid Berhad Company Information
Table 153. Hovid Berhad Business Overview
Table 154. Hovid Berhad Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 155. Hovid Berhad Generic Drugs Product Portfolio
Table 156. Hovid Berhad Recent Development
Table 157. Duopharma Biotech Company Information
Table 158. Duopharma Biotech Business Overview
Table 159. Duopharma Biotech Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 160. Duopharma Biotech Generic Drugs Product Portfolio
Table 161. Duopharma Biotech Recent Development
Table 162. Kotra Pharma Company Information
Table 163. Kotra Pharma Business Overview
Table 164. Kotra Pharma Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 165. Kotra Pharma Generic Drugs Product Portfolio
Table 166. Kotra Pharma Recent Development
Table 167. HOE Pharmaceutical Company Information
Table 168. HOE Pharmaceutical Business Overview
Table 169. HOE Pharmaceutical Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 170. HOE Pharmaceutical Generic Drugs Product Portfolio
Table 171. HOE Pharmaceutical Recent Development
Table 172. Y.S.P. Industries Company Information
Table 173. Y.S.P. Industries Business Overview
Table 174. Y.S.P. Industries Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 175. Y.S.P. Industries Generic Drugs Product Portfolio
Table 176. Y.S.P. Industries Recent Development
Table 177. North America Generic Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 178. North America Generic Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 179. North America Generic Drugs Market Share by Country (2019-2024)
Table 180. North America Generic Drugs Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 181. North America Generic Drugs Market Share Forecast by Country (2025-2030)
Table 182. Europe Generic Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 183. Europe Generic Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 184. Europe Generic Drugs Market Share by Country (2019-2024)
Table 185. Europe Generic Drugs Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 186. Europe Generic Drugs Market Share Forecast by Country (2025-2030)
Table 187. Asia-Pacific Generic Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 188. Asia-Pacific Generic Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 189. Asia-Pacific Generic Drugs Market Share by Country (2019-2024)
Table 190. Asia-Pacific Generic Drugs Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 191. Asia-Pacific Generic Drugs Market Share Forecast by Country (2025-2030)
Table 192. Latin America Generic Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 193. Latin America Generic Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 194. Latin America Generic Drugs Market Share by Country (2019-2024)
Table 195. Latin America Generic Drugs Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 196. Latin America Generic Drugs Market Share Forecast by Country (2025-2030)
Table 197. Middle East & Africa Generic Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 198. Middle East & Africa Generic Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 199. Middle East & Africa Generic Drugs Market Share by Country (2019-2024)
Table 200. Middle East & Africa Generic Drugs Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 201. Middle East & Africa Generic Drugs Market Share Forecast by Country (2025-2030)
Table 202. Research Programs/Design for This Report
Table 203. Authors List of This Report
Table 204. Secondary Sources
Table 205. Primary Sources
Table 1. Global Generic Drugs Market Size (US$ Million) Comparison by Region: 2019 VS 2023 VS 2030
Table 2. Global Generic Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 3. Global Generic Drugs Market Share by Region (2019-2024)
Table 4. Global Generic Drugs Market Size by Region (2025-2030) & (US$ Million)
Table 5. Global Generic Drugs Market Share by Region (2025-2030)
Table 6. Global Generic Drugs Market Size by Type (2019 VS 2023 VS 2030) & (US$ Million)
Table 7. Global Generic Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 8. Global Generic Drugs Market Size Share by Type (2019-2024)
Table 9. Global Generic Drugs Market Size Forecasted by Type (2025-2030) & (US$ Million)
Table 10. Global Generic Drugs Market Size Share Forecasted by Type (2025-2030)
Table 11. North America Generic Drugs Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 12. North America Generic Drugs Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 13. Europe Generic Drugs Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 14. Europe Generic Drugs Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 15. Asia-Pacific Generic Drugs Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 16. Asia-Pacific Generic Drugs Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 17. Latin America Generic Drugs Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 18. Latin America Generic Drugs Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 19. Middle East and Africa Generic Drugs Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 20. Middle East and Africa Generic Drugs Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 21. Global Generic Drugs Market Size by Application (2019 VS 2023 VS 2030) & (US$ Million)
Table 22. Global Generic Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 23. Global Generic Drugs Market Size Share by Application (2019-2024)
Table 24. Global Generic Drugs Market Size Forecasted by Application (2025-2030) & (US$ Million)
Table 25. Global Generic Drugs Market Size Share Forecasted by Application (2025-2030)
Table 26. North America Generic Drugs Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 27. North America Generic Drugs Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 28. Europe Generic Drugs Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 29. Europe Generic Drugs Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 30. Asia-Pacific Generic Drugs Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 31. Asia-Pacific Generic Drugs Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 32. Latin America Generic Drugs Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 33. Latin America Generic Drugs Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 34. Middle East and Africa Generic Drugs Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 35. Middle East and Africa Generic Drugs Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 36. Generic Drugs Industry Trends
Table 37. Generic Drugs Industry Drivers
Table 38. Generic Drugs Industry Opportunities and Challenges
Table 39. Generic Drugs Industry Restraints
Table 40. Global Generic Drugs Revenue by Company (US$ Million) & (2019-2024)
Table 41. Global Generic Drugs Revenue Market Share by Company (2019-2024)
Table 42. Global Generic Drugs Industry Company Ranking, 2022 VS 2023 VS 2024
Table 43. Global Generic Drugs Key Company Headquarters & Area Served
Table 44. Global Generic Drugs Company, Product Type & Application
Table 45. Global Generic Drugs Company Commercialization Time
Table 46. Global Company Market Concentration Ratio (CR5 and HHI)
Table 47. Global Generic Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 48. Teva Business Overview
Table 49. Teva Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 50. Teva Generic Drugs Product Portfolio
Table 51. Teva Recent Development
Table 52. Novartis - Sandoz Company Information
Table 53. Novartis - Sandoz Business Overview
Table 54. Novartis - Sandoz Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 55. Novartis - Sandoz Generic Drugs Product Portfolio
Table 56. Novartis - Sandoz Recent Development
Table 57. Mylan Company Information
Table 58. Mylan Business Overview
Table 59. Mylan Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 60. Mylan Generic Drugs Product Portfolio
Table 61. Mylan Recent Development
Table 62. Sun Pharmaceutical Company Information
Table 63. Sun Pharmaceutical Business Overview
Table 64. Sun Pharmaceutical Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 65. Sun Pharmaceutical Generic Drugs Product Portfolio
Table 66. Sun Pharmaceutical Recent Development
Table 67. Aspen Company Information
Table 68. Aspen Business Overview
Table 69. Aspen Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 70. Aspen Generic Drugs Product Portfolio
Table 71. Aspen Recent Development
Table 72. Fresenius Kabi Company Information
Table 73. Fresenius Kabi Business Overview
Table 74. Fresenius Kabi Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 75. Fresenius Kabi Generic Drugs Product Portfolio
Table 76. Fresenius Kabi Recent Development
Table 77. Pfizer (Hospira) Company Information
Table 78. Pfizer (Hospira) Business Overview
Table 79. Pfizer (Hospira) Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 80. Pfizer (Hospira) Generic Drugs Product Portfolio
Table 81. Pfizer (Hospira) Recent Development
Table 82. Sanofi Company Information
Table 83. Sanofi Business Overview
Table 84. Sanofi Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 85. Sanofi Generic Drugs Product Portfolio
Table 86. Sanofi Recent Development
Table 87. Aurobindo Company Information
Table 88. Aurobindo Business Overview
Table 89. Aurobindo Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 90. Aurobindo Generic Drugs Product Portfolio
Table 91. Aurobindo Recent Development
Table 92. Lupin Company Information
Table 93. Lupin Business Overview
Table 94. Lupin Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 95. Lupin Generic Drugs Product Portfolio
Table 96. Lupin Recent Development
Table 97. Dr. Reddy's Company Information
Table 98. Dr. Reddy's Business Overview
Table 99. Dr. Reddy's Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 100. Dr. Reddy's Generic Drugs Product Portfolio
Table 101. Dr. Reddy's Recent Development
Table 102. Apotex Company Information
Table 103. Apotex Business Overview
Table 104. Apotex Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 105. Apotex Generic Drugs Product Portfolio
Table 106. Apotex Recent Development
Table 107. Cipla Company Information
Table 108. Cipla Business Overview
Table 109. Cipla Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 110. Cipla Generic Drugs Product Portfolio
Table 111. Cipla Recent Development
Table 112. ENDO (Par Pharmaceutical) Company Information
Table 113. ENDO (Par Pharmaceutical) Business Overview
Table 114. ENDO (Par Pharmaceutical) Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 115. ENDO (Par Pharmaceutical) Generic Drugs Product Portfolio
Table 116. ENDO (Par Pharmaceutical) Recent Development
Table 117. Stada Arzneimittel Company Information
Table 118. Stada Arzneimittel Business Overview
Table 119. Stada Arzneimittel Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 120. Stada Arzneimittel Generic Drugs Product Portfolio
Table 121. Stada Arzneimittel Recent Development
Table 122. Krka Group Company Information
Table 123. Krka Group Business Overview
Table 124. Krka Group Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 125. Krka Group Generic Drugs Product Portfolio
Table 126. Krka Group Recent Development
Table 127. Nichi-Iko Pharmaceutical Company Information
Table 128. Nichi-Iko Pharmaceutical Business Overview
Table 129. Nichi-Iko Pharmaceutical Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 130. Nichi-Iko Pharmaceutical Generic Drugs Product Portfolio
Table 131. Nichi-Iko Pharmaceutical Recent Development
Table 132. Valeant Company Information
Table 133. Valeant Business Overview
Table 134. Valeant Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 135. Valeant Generic Drugs Product Portfolio
Table 136. Valeant Recent Development
Table 137. Zydus Cadila Company Information
Table 138. Zydus Cadila Business Overview
Table 139. Zydus Cadila Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 140. Zydus Cadila Generic Drugs Product Portfolio
Table 141. Zydus Cadila Recent Development
Table 142. Hikma Company Information
Table 143. Hikma Business Overview
Table 144. Hikma Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 145. Hikma Generic Drugs Product Portfolio
Table 146. Hikma Recent Development
Table 147. Pharmaniaga Berhad Company Information
Table 148. Pharmaniaga Berhad Business Overview
Table 149. Pharmaniaga Berhad Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 150. Pharmaniaga Berhad Generic Drugs Product Portfolio
Table 151. Pharmaniaga Berhad Recent Development
Table 152. Hovid Berhad Company Information
Table 153. Hovid Berhad Business Overview
Table 154. Hovid Berhad Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 155. Hovid Berhad Generic Drugs Product Portfolio
Table 156. Hovid Berhad Recent Development
Table 157. Duopharma Biotech Company Information
Table 158. Duopharma Biotech Business Overview
Table 159. Duopharma Biotech Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 160. Duopharma Biotech Generic Drugs Product Portfolio
Table 161. Duopharma Biotech Recent Development
Table 162. Kotra Pharma Company Information
Table 163. Kotra Pharma Business Overview
Table 164. Kotra Pharma Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 165. Kotra Pharma Generic Drugs Product Portfolio
Table 166. Kotra Pharma Recent Development
Table 167. HOE Pharmaceutical Company Information
Table 168. HOE Pharmaceutical Business Overview
Table 169. HOE Pharmaceutical Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 170. HOE Pharmaceutical Generic Drugs Product Portfolio
Table 171. HOE Pharmaceutical Recent Development
Table 172. Y.S.P. Industries Company Information
Table 173. Y.S.P. Industries Business Overview
Table 174. Y.S.P. Industries Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 175. Y.S.P. Industries Generic Drugs Product Portfolio
Table 176. Y.S.P. Industries Recent Development
Table 177. North America Generic Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 178. North America Generic Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 179. North America Generic Drugs Market Share by Country (2019-2024)
Table 180. North America Generic Drugs Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 181. North America Generic Drugs Market Share Forecast by Country (2025-2030)
Table 182. Europe Generic Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 183. Europe Generic Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 184. Europe Generic Drugs Market Share by Country (2019-2024)
Table 185. Europe Generic Drugs Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 186. Europe Generic Drugs Market Share Forecast by Country (2025-2030)
Table 187. Asia-Pacific Generic Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 188. Asia-Pacific Generic Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 189. Asia-Pacific Generic Drugs Market Share by Country (2019-2024)
Table 190. Asia-Pacific Generic Drugs Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 191. Asia-Pacific Generic Drugs Market Share Forecast by Country (2025-2030)
Table 192. Latin America Generic Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 193. Latin America Generic Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 194. Latin America Generic Drugs Market Share by Country (2019-2024)
Table 195. Latin America Generic Drugs Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 196. Latin America Generic Drugs Market Share Forecast by Country (2025-2030)
Table 197. Middle East & Africa Generic Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 198. Middle East & Africa Generic Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 199. Middle East & Africa Generic Drugs Market Share by Country (2019-2024)
Table 200. Middle East & Africa Generic Drugs Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 201. Middle East & Africa Generic Drugs Market Share Forecast by Country (2025-2030)
Table 202. Research Programs/Design for This Report
Table 203. Authors List of This Report
Table 204. Secondary Sources
Table 205. Primary Sources
LIST OF FIGURES
Figure 1. Generic Drugs Product Picture
Figure 2. Global Generic Drugs Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Generic Drugs Market Size (2019-2030) & (US$ Million)
Figure 4. Global Generic Drugs Market Share by Region: 2023 VS 2030
Figure 5. Global Generic Drugs Market Share by Region (2019-2030)
Figure 6. North America Generic Drugs Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 7. Europe Generic Drugs Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 8. Asia-Pacific Generic Drugs Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 9. Latin America Generic Drugs Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 10. Middle East & Africa Generic Drugs Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 11. Product Picture of Prescription
Figure 12. Global Prescription Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 13. Product Picture of Non-Prescription Drugs
Figure 14. Global Non-Prescription Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 15. Global Generic Drugs Market Size Overview by Type (2019-2030) & (US$ Million)
Figure 16. Global Generic Drugs Market Share by Type 2023 VS 2030
Figure 17. North America Generic Drugs Market Size Share by Type (2019-2030)
Figure 18. Europe Generic Drugs Market Size Share by Type (2019-2030)
Figure 19. Asia-Pacific Generic Drugs Market Size Share by Type (2019-2030)
Figure 20. Latin America Generic Drugs Market Size Share by Type (2019-2030)
Figure 21. Middle East and Africa Generic Drugs Market Size Share by Type (2019-2030)
Figure 22. Product Picture of Hospital
Figure 23. Global Hospital Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Product Picture of Clinic
Figure 25. Global Clinic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Product Picture of Others
Figure 27. Global Others Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Global Generic Drugs Market Size Overview by Application (2019-2030) & (US$ Million)
Figure 29. Global Generic Drugs Market Share by Application 2023 VS 2030
Figure 30. North America Generic Drugs Market Size Share by Application (2019-2030)
Figure 31. Europe Generic Drugs Market Size Share by Application (2019-2030)
Figure 32. Asia-Pacific Generic Drugs Market Size Share by Application (2019-2030)
Figure 33. Latin America Generic Drugs Market Size Share by Application (2019-2030)
Figure 34. Middle East and Africa Generic Drugs Market Size Share by Application (2019-2030)
Figure 35. Global Top 5 and 10 Generic Drugs Players Market Share by Revenue in 2023
Figure 36. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 37. North America Generic Drugs Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 38. North America Generic Drugs Market Share by Country: 2019 VS 2023 VS 2030
Figure 39. North America Generic Drugs Market Share by Country (2019-2030)
Figure 40. Europe Generic Drugs Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 41. Europe Generic Drugs Market Share by Country: 2019 VS 2023 VS 2030
Figure 42. Europe Generic Drugs Market Share by Country (2019-2030)
Figure 43. Asia-Pacific Generic Drugs Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 44. Asia-Pacific Generic Drugs Market Share by Country: 2019 VS 2023 VS 2030
Figure 45. Asia-Pacific Generic Drugs Market Share by Country (2019-2030)
Figure 46. Latin America Generic Drugs Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 47. Latin America Generic Drugs Market Share by Country: 2019 VS 2023 VS 2030
Figure 48. Latin America Generic Drugs Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Generic Drugs Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 50. Middle East & Africa Generic Drugs Market Share by Country: 2019 VS 2023 VS 2030
Figure 51. Middle East & Africa Generic Drugs Market Share by Country (2019-2030)
Figure 52. Years Considered
Figure 53. Research Process
Figure 54. Key Executives Interviewed
Figure 1. Generic Drugs Product Picture
Figure 2. Global Generic Drugs Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Generic Drugs Market Size (2019-2030) & (US$ Million)
Figure 4. Global Generic Drugs Market Share by Region: 2023 VS 2030
Figure 5. Global Generic Drugs Market Share by Region (2019-2030)
Figure 6. North America Generic Drugs Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 7. Europe Generic Drugs Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 8. Asia-Pacific Generic Drugs Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 9. Latin America Generic Drugs Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 10. Middle East & Africa Generic Drugs Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 11. Product Picture of Prescription
Figure 12. Global Prescription Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 13. Product Picture of Non-Prescription Drugs
Figure 14. Global Non-Prescription Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 15. Global Generic Drugs Market Size Overview by Type (2019-2030) & (US$ Million)
Figure 16. Global Generic Drugs Market Share by Type 2023 VS 2030
Figure 17. North America Generic Drugs Market Size Share by Type (2019-2030)
Figure 18. Europe Generic Drugs Market Size Share by Type (2019-2030)
Figure 19. Asia-Pacific Generic Drugs Market Size Share by Type (2019-2030)
Figure 20. Latin America Generic Drugs Market Size Share by Type (2019-2030)
Figure 21. Middle East and Africa Generic Drugs Market Size Share by Type (2019-2030)
Figure 22. Product Picture of Hospital
Figure 23. Global Hospital Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Product Picture of Clinic
Figure 25. Global Clinic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Product Picture of Others
Figure 27. Global Others Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Global Generic Drugs Market Size Overview by Application (2019-2030) & (US$ Million)
Figure 29. Global Generic Drugs Market Share by Application 2023 VS 2030
Figure 30. North America Generic Drugs Market Size Share by Application (2019-2030)
Figure 31. Europe Generic Drugs Market Size Share by Application (2019-2030)
Figure 32. Asia-Pacific Generic Drugs Market Size Share by Application (2019-2030)
Figure 33. Latin America Generic Drugs Market Size Share by Application (2019-2030)
Figure 34. Middle East and Africa Generic Drugs Market Size Share by Application (2019-2030)
Figure 35. Global Top 5 and 10 Generic Drugs Players Market Share by Revenue in 2023
Figure 36. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 37. North America Generic Drugs Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 38. North America Generic Drugs Market Share by Country: 2019 VS 2023 VS 2030
Figure 39. North America Generic Drugs Market Share by Country (2019-2030)
Figure 40. Europe Generic Drugs Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 41. Europe Generic Drugs Market Share by Country: 2019 VS 2023 VS 2030
Figure 42. Europe Generic Drugs Market Share by Country (2019-2030)
Figure 43. Asia-Pacific Generic Drugs Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 44. Asia-Pacific Generic Drugs Market Share by Country: 2019 VS 2023 VS 2030
Figure 45. Asia-Pacific Generic Drugs Market Share by Country (2019-2030)
Figure 46. Latin America Generic Drugs Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 47. Latin America Generic Drugs Market Share by Country: 2019 VS 2023 VS 2030
Figure 48. Latin America Generic Drugs Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Generic Drugs Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 50. Middle East & Africa Generic Drugs Market Share by Country: 2019 VS 2023 VS 2030
Figure 51. Middle East & Africa Generic Drugs Market Share by Country (2019-2030)
Figure 52. Years Considered
Figure 53. Research Process
Figure 54. Key Executives Interviewed
